GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor

Analyse Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2QU5
Type
protein
Length
292 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor receptor 2
EC
2.7.10.1
UniProt
P35968
Ligands
276
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein29239% helix, 16% strandP35968

Ligands and binding sites

  • 276 · 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12870.750.8737276
21360.420.7537empty
3600.340.7714empty

Compared structures

  • 2QU5 · Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P35968 · AlphaFold monomer V2.0 prediction for vascular endothelial growth factor receptor 2… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.